HeartBeam prices $10M public offering of 5.88M shares at $1.70 per share

HeartBeam, Inc.

Offering of 5,882,353 shares of common stock at $1.70/share; gross proceeds ~$10M.
Underwriter granted 588,235 warrants at $2.125/share, exercisable from Feb 2026 to Feb 2030.
Directors and officers subject to 180-day lock-up; company restricted from issuing equity for 180 days.
Net proceeds to fund commercial-readiness, R&D, regulatory projects, working capital.
FDA cleared HeartBeam system for arrhythmia; 510(k) submitted for 12-lead ECG synthesis software.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.